These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23937979)

  • 1. Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.
    Sunohara K; Mitsuhashi S; Shigetomi K; Ubukata M
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5140-4. PubMed ID: 23937979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
    Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
    Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD-based inhibitors with anticancer potential.
    Felczak K; Vince R; Pankiewicz KW
    Bioorg Med Chem Lett; 2014 Jan; 24(1):332-6. PubMed ID: 24269162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.
    Chen L; Wilson D; Jayaram HN; Pankiewicz KW
    J Med Chem; 2007 Dec; 50(26):6685-91. PubMed ID: 18038969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
    Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
    Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E. coli gpt gene expression effects on K562 human leukemia cell proliferation and erythroid differentiation altered by mycophenolic acid.
    Kamano H; Tanaka T; Yamaji Y; Ikeda K; Hata Y; Shiotani T; Ishida T; Takahara J; Irino S
    Biochem Int; 1992 Mar; 26(3):537-43. PubMed ID: 1627163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
    Pankiewicz KW; Lesiak-Watanabe KB; Watanabe KA; Patterson SE; Jayaram HN; Yalowitz JA; Miller MD; Seidman M; Majumdar A; Prehna G; Goldstein BM
    J Med Chem; 2002 Jan; 45(3):703-12. PubMed ID: 11806722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors.
    Zhang J; Cao J; Xu L; Zhou Y; Liu T; Li J; Hu Y
    Bioorg Med Chem; 2014 Jun; 22(11):2955-65. PubMed ID: 24767818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
    Shah CP; Kharkar PS
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):972-977. PubMed ID: 29792360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
    Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
    Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
    Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
    Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
    Shah CP; Kharkar PS
    Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.
    Buckley GM; Davies N; Dyke HJ; Gilbert PJ; Hannah DR; Haughan AF; Hunt CA; Pitt WR; Profit RH; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
    Bioorg Med Chem Lett; 2005 Feb; 15(3):751-4. PubMed ID: 15664851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
    Wittine K; Stipković Babić M; Makuc D; Plavec J; Kraljević Pavelić S; Sedić M; Pavelić K; Leyssen P; Neyts J; Balzarini J; Mintas M
    Bioorg Med Chem; 2012 Jun; 20(11):3675-85. PubMed ID: 22555152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
    Wright DG; Boosalis M; Malek K; Waraska K
    Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.
    Lesiak K; Watanabe KA; Majumdar A; Powell J; Seidman M; Vanderveen K; Goldstein BM; Pankiewicz KW
    J Med Chem; 1998 Feb; 41(4):618-22. PubMed ID: 9484510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.
    Chong CR; Qian DZ; Pan F; Wei Y; Pili R; Sullivan DJ; Liu JO
    J Med Chem; 2006 May; 49(9):2677-80. PubMed ID: 16640327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.
    Liao V; Liu T; Codd R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6200-4. PubMed ID: 22932316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.